Use of the Laboratory in Prediction of Outcome in the High-Risk Newborn (Nacb Symposium) Use of the Laboratory in Prediction of Outcome in the High-Risk Newborn (Nacb Symposium)

Use of the Laboratory in Prediction of Outcome in the High-Risk Newborn (Nacb Symposium‪)‬

Clinical Chemistry 1997, Jan, 43, 1

    • $5.99
    • $5.99

Publisher Description

The concept that the laboratory plays a role in outcome assessment of the high-risk newborn is a new one. This paper reviews the prediction of survival and neurodevelopmental status in the newborn period. Development is defined as the process of growth and differentiation [1]. Neurodevelopment refers more specifically to the nervous system, and in this paper refers to the acquisition of developmental milestones (e.g., walking, talking, reading, writing). Neurodevelopmental status reflects not only the functional adequacy of the maturing brain, but also other factors such as the senses, the motor system, and the environment (e.g., stimulation provided by parents). The term "outcome" indicates the neurodevelopmental or functional state of a child as a result of a neonatal condition.

GENRE
Science & Nature
RELEASED
1997
January 1
LANGUAGE
EN
English
LENGTH
16
Pages
PUBLISHER
American Association for Clinical Chemistry, Inc.
SELLER
The Gale Group, Inc., a Delaware corporation and an affiliate of Cengage Learning, Inc.
SIZE
186.4
KB
Diagnosis of Neonatal Sepsis: A Clinical and Laboratory Challenge (Opinion) Diagnosis of Neonatal Sepsis: A Clinical and Laboratory Challenge (Opinion)
2004
Association of Transcutaneous Bilirubin Testing in Hospital with Decreased Readmission Rate for Hyperbilirubinemia (Evidence-Based Laboratory Medicine and Test Utilization) Association of Transcutaneous Bilirubin Testing in Hospital with Decreased Readmission Rate for Hyperbilirubinemia (Evidence-Based Laboratory Medicine and Test Utilization)
2005
Assessing Fluid and Electrolyte Status in the Newborn (Nacb Symposium) Assessing Fluid and Electrolyte Status in the Newborn (Nacb Symposium)
1997
Biochemical and Molecular Basis of Pediatric Disease Biochemical and Molecular Basis of Pediatric Disease
2021
Cambridge Studies in Biological and Evolutionary Anthropology Cambridge Studies in Biological and Evolutionary Anthropology
2011
Building Babies Building Babies
2012
Genetic Variation in the MTHFR Gene Influences Thiopurine Methyltransferase Activity (Technical Briefs) Genetic Variation in the MTHFR Gene Influences Thiopurine Methyltransferase Activity (Technical Briefs)
2005
C677T and AI298C Polymorphisms of the Methylenetetrahydrofolate Reductase Gene: Incidence and Effect of Combined Genotypes on Plasma Fasting and Post-Methionine Load Homocysteine in Vascular Disease (Molecular Diagnostics and Genetics) C677T and AI298C Polymorphisms of the Methylenetetrahydrofolate Reductase Gene: Incidence and Effect of Combined Genotypes on Plasma Fasting and Post-Methionine Load Homocysteine in Vascular Disease (Molecular Diagnostics and Genetics)
2001
The Costs of Disease (Laboratory Management) The Costs of Disease (Laboratory Management)
2000
Reproducibility in Protein Profiling by MALDI-TOF Mass Spectrometry (Proteomics and Protein Markers) Reproducibility in Protein Profiling by MALDI-TOF Mass Spectrometry (Proteomics and Protein Markers)
2007
Why a Cluster is Truly a Cluster: Insulin Resistance and Cardiovascular Disease (Perspective) Why a Cluster is Truly a Cluster: Insulin Resistance and Cardiovascular Disease (Perspective)
2008
D-Dimer Testing for Deep Venous Thrombosis: A Metaanalysis (Clinical Report) D-Dimer Testing for Deep Venous Thrombosis: A Metaanalysis (Clinical Report)
2004